Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Inventory (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Inventory for 16 consecutive years, with $6.2 million as the latest value for Q4 2025.

  • Quarterly Inventory rose 55.64% to $6.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.2 million through Dec 2025, up 55.64% year-over-year, with the annual reading at $6.2 million for FY2025, 55.64% up from the prior year.
  • Inventory hit $6.2 million in Q4 2025 for Cumberland Pharmaceuticals, up from $2.9 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $10.9 million in Q2 2023 to a low of $2.9 million in Q3 2025.
  • Historically, Inventory has averaged $7.3 million across 5 years, with a median of $8.6 million in 2021.
  • Biggest five-year swings in Inventory: plummeted 60.63% in 2024 and later soared 55.64% in 2025.
  • Year by year, Inventory stood at $8.4 million in 2021, then grew by 17.01% to $9.9 million in 2022, then plummeted by 53.27% to $4.6 million in 2023, then fell by 13.22% to $4.0 million in 2024, then skyrocketed by 55.64% to $6.2 million in 2025.
  • Business Quant data shows Inventory for CPIX at $6.2 million in Q4 2025, $2.9 million in Q3 2025, and $3.2 million in Q2 2025.